Characteristics of patients with myeloproliferative neoplasms with lymphoma, with or without JAK inhibitor therapy

Naveen Pemmaraju, Hagop Kantarjian, Loretta Nastoupil, Megan Dupuis, Lisa Zhou, Sherry Pierce, Keyur P. Patel, Lucia Masarova, Jorge Cortes and Srdan Verstovsek
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.